A profound transformation is sweeping through the halls of biomedical research, driven by the powerful convergence of artificial intelligence and large-scale genomics. This is not merely an incremental improvement on existing methods; it represents a fundamental paradigm shift, moving science from
The human immune system stands as a formidable biological fortress, meticulously designed to identify and annihilate threats ranging from common viruses to nascent cancer cells, but a landmark analysis has illuminated a disturbing scenario where this defense system's own soldiers can be corrupted
The pharmaceutical industry stands at a critical juncture, contending with a deep and persistent deficit of public trust that can significantly impede medical progress and patient care. While this challenge is formidable, it is not an insurmountable barrier to a more collaborative future. Recent
With a deep background in biopharma and a keen eye on the intersection of technology and research, Ivan Kairatov has become a leading voice on innovative public health strategies. Today, he joins us to discuss a unique cause-marketing campaign that transforms the retail experience into a powerful
In the high-stakes world of pharmaceutical development, not all clinical successes translate to commercial triumphs, a reality starkly illustrated when Amgen announced it was terminating its partnership with Kyowa Kirin for the eczema drug rocatinlimab, handing back the rights to a once-promising
Today we are speaking with Ivan Kairatov, a biopharma expert with deep insight into the intersection of technology and research in mental healthcare. We will be exploring the UK's ambitious new Mental Health Goals programme, a transformative initiative poised to reshape how we understand and treat
